Assessing Blue Owl Capital (OWL) Valuation After Recent Share Price Rebound And Earnings Multiple Signals
Recent performance snapshot
Blue Owl Capital (OWL) has drawn fresh attention after a recent 1 day return of 2.36% and a month gain of 16.45%, set against a past 3 months decline of 25.63%.
See our latest analysis for Blue Owl Capital.
At a share price of US$9.98, Blue Owl Capital has recently seen short term momentum pick up, with a 7 day share price return of 8.71% and a 30 day share price return of 16.45% set against a weaker year to date share price return of 34.81% and a 1 year total shareholder return of 42.58%. Recent gains therefore follow a tougher period for longer term holders.
If this kind of rebound has you thinking about where else capital might work harder, it could be a good moment to size up 18 top founder-led companies
With Blue Owl Capital trading at US$9.98 against an average analyst price target of US$12.80 and recent returns still weak over 1 year, is this a mispriced recovery story, or are markets already banking on future growth?
Most Popular Narrative: 33.2% Undervalued
With Blue Owl Capital at $9.98 against a narrative fair value of $14.93, the most followed view frames the current price as a steep discount built on specific earnings and margin assumptions.
Significant ongoing growth in permanent capital vehicles, particularly through expansion in private credit, real assets, and evergreen or interval fund strategies, is providing stable and recurring management fee revenue and positioning Blue Owl for higher future earnings and durable margin expansion. Structural shifts away from traditional bank lending toward private lenders, combined with robust demand for alternative credit and asset backed finance, are enabling large pipeline growth and high deployment opportunities, directly supporting future AUM growth and upward trajectory in revenues.
Want to see what sits underneath that optimism on fees and margins? The narrative focuses on compounded earnings growth, richer profitability, and a reset earnings multiple. Curious which assumptions really carry the valuation story? The full breakdown lays out the playbook behind that $14.93 fair value line by line.
Result: Fair Value of $14.93 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, sentiment could still sour if fundraising slows or acquisition integrations disappoint, which could put pressure on Blue Owl's fee growth assumptions and margin targets.
Find out about the key risks to this Blue Owl Capital narrative.
Another take on value: earnings multiple check
The narrative fair value paints Blue Owl Capital as 33.2% undervalued, but the current P/E of 77.6x tells a different story. That is well above the US Capital Markets industry at 41.9x, peers at 29.2x, and a fair ratio of 20x, which lifts valuation risk if expectations slip.
To see how that earnings multiple stacks up in more detail, including how it compares with peers and the fair ratio the market could move towards, have a look at See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With optimism and concern both in the mix, you do not have to rely on anyone else's view. Instead, check the 1 key reward and 3 important warning signs.
Ready to size up your next ideas?
Do not stop at a single stock. Use the screener to quickly surface new opportunities that fit your style before other investors pay attention.
- Target quality and value together by scanning for companies that look mispriced on fundamentals with the 51 high quality undervalued stocks
- Prioritise resilience by reviewing companies screened for financial strength and healthy balance sheets through the solid balance sheet and fundamentals stocks screener (44 results)
- Spot under the radar opportunities by searching a screener containing 25 high quality undiscovered gems
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com